Sue Meng is a corporate partner and member of the firm’s Mergers & Acquisitions and Private Equity Groups. Ms. Meng is Co-Chair of the firm’s Pro Bono Committee. Her practice focuses on advising private equity firms, public companies, boards of directors and special committees, in connection with mergers and acquisitions and other significant corporate matters.
She is noted as Up and Coming for M&A by Chambers USA (2018), where clients say “[s]he is a brilliant lawyer, hard-working and simply a good person.” Ms. Meng was named a “Rising Star” in M&A by Law360 (2018), awarded to lawyers under the age of 40 “whose legal accomplishments transcend their age.”
Ms. Meng joined Debevoise in 2010. Ms. Meng received a J.D. from Yale Law School in 2010, where she was a Coker Fellow and an editor of the Yale Journal of International Law. While at Yale, Ms. Meng was a recipient of a Paul and Daisy Soros Fellowship for New Americans.
Ms. Meng received a M.St. with distinction in English Literature and a M.Phil with distinction in Modern Chinese Studies from Oxford University, which she attended as a Rhodes Scholar. She received an A.B. magna cum laude with highest honors from Harvard University. She is fluent in Mandarin Chinese.
Ms. Meng serves on the Board of Trustees for Prep for Prep and on the selection committee for the Schwarzman Scholars. She has also served as Secretary of the Alumnae Board of the Brearley School and on the national selection committee for the Rhodes Scholarships and Soros Fellowships. Ms. Meng has been published in The Washington Post and The Harvard Review. Ms. Meng is a term member of the Council on Foreign Relations.
- Risk Strategies in its acquisition of Krauter & Company, a leading specialty firm focused on the risk and insurance needs of private equity firms and their portfolio companies nationwide.
- NJRetina in the formation of a strategic affiliation with NJEye and Quad-C Management.
- Providence Service Corporation and LogistiCare in LogistiCare’s acquisition of Circulation, a provider of technology-enabled logistics solutions and analytics for managing non-emergency transportation across healthcare.
- Risk Strategies, a Kelso & Company portfolio company, in its acquisition of Oxford Risk Management, an established leader in alternative risk and captive insurance and consulting.
- Cerberus Capital Management in its acquisition of Electrical Components International, the world’s leading manufacturer of wire harnesses, control boxes and value-added assembly services, from KPS Capital Partners.
- Johnson & Johnson in its global co-development and commercialization agreement with Theravance Biopharma, relating to various compounds being developed for the treatment of inflammatory bowel disease, including Crohn’s and ulcerative colitis.
- Clayton, Dubilier & Rice in the acquisition of Carestream Dental, the digital dental business of Carestream Health.
- Allergan in its $2.9 billion acquisition of LifeCell Corporation, a regenerative medicine business.
- Allergan in its $639 million acquisition of Vitae Pharmaceuticals, a clinical-stage biotechnology company.
- Envision Healthcare in its $15 billion merger with AMSURG, creating one of the largest U.S. providers of specialty physicians and hospital-related services.
- Providence Equity Partners in its acquisition from General Motors and Ford of a majority stake in OEConnection, the established market leader in cloud-based technology solutions that facilitate the efficient location, sale, distribution and dynamic pricing of automotive parts.
- International Paper in its $2.2 billion acquisition of Weyerhaeuser’s pulp business.
- Evercore Group as financial advisor to Rovi Corporation in its $1.1 billion acquisition of TiVo.
- Guardian Life in the acquisition by its subsidiary, Reed Group, of the absence management administration business of Aon Hewitt.
- Kelso & Company in its acquisition of Risk Strategies Company, a national insurance and benefits brokerage and risk management firm, from Kohlberg & Company.
- Envision Healthcare in its $620 million acquisition of Rural/Metro Corporation.
StanCorp Financial Group in its $5 billion sale to Meiji Yasuda Life Insurance Company.
- Independent Committee of the Board of Directors of Martha Stewart Living Omnimedia in its $365 million sale to Sequential Brands.
- Healogics, a Clayton, Dubilier & Rice portfolio company, in its acquisition of Accelecare Wound Centers.
- Pediatric Services Holding Corporation, the parent of Pediatric Services of America, in its sale to J.H. Whitney Capital Partners.
- Protective Life in its $5.7 billion merger with a subsidiary of Dai-ichi Life, a life insurance company listed on the Tokyo stock exchange.
- Clayton, Dubilier & Rice in its $910 million acquisition of Healogics, the largest advanced wound care services provider in the U.S.
- The Special Committee of the Board of Directors of Dell in the $24.9 billion sale of Dell to an investor group including Michael Dell and Silver Lake.
- Beijing Galloping Horse Film and Galloping Horse America in their acquisition of the visual effects and other assets of Digital Domain Productions in a Section 363 sale under the U.S. Bankruptcy Code.
- Clayton, Dubilier & Rice in its $1.05 billion acquisition of David’s Bridal.
- Verizon Communications in its $612 million acquisition of Hughes Telematics.
- J.C. Flowers and Crump Group in the sale of the life and property and casualty insurance divisions of Crump to BB&T Corporation.
- International Paper in its $4.3 billion acquisition of Temple-Inland.
- Yale Law School, 2010, J.D.
- University of Oxford, 2006, M.Phil.
- Harvard University, 2003, A.B.
- New York
Rate : $$$